283 related articles for article (PubMed ID: 26518582)
1. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
[TBL] [Abstract][Full Text] [Related]
2. MRI surveillance for the detection of local recurrence in rectal cancer after transanal endoscopic microsurgery.
Hupkens BJP; Maas M; Martens MH; Deserno WMLLG; Leijtens JWA; Nelemans PJ; Bakers FCH; Lambregts DMJ; Beets GL; Beets-Tan RGH
Eur Radiol; 2017 Dec; 27(12):4960-4969. PubMed ID: 28667480
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
[TBL] [Abstract][Full Text] [Related]
4. Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer.
Molinelli V; Angeretti MG; Duka E; Tarallo N; Bracchi E; Novario R; Fugazzola C
Abdom Radiol (NY); 2018 Nov; 43(11):2903-2912. PubMed ID: 29541831
[TBL] [Abstract][Full Text] [Related]
5. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
[TBL] [Abstract][Full Text] [Related]
6. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
[TBL] [Abstract][Full Text] [Related]
7. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer.
Lambregts DM; Cappendijk VC; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2011 Jun; 21(6):1250-8. PubMed ID: 21240647
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
Sassen S; de Booij M; Sosef M; Berendsen R; Lammering G; Clarijs R; Bakker M; Beets-Tan R; Warmerdam F; Vliegen R
Eur Radiol; 2013 Dec; 23(12):3440-9. PubMed ID: 23832319
[TBL] [Abstract][Full Text] [Related]
9. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration.
Fornell-Perez R; Perez-Alonso E; Porcel-de-Peralta G; Duran-Castellon A; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Orihuela-de-la-Cal ME; Loro-Ferrer JF
Abdom Radiol (NY); 2019 Nov; 44(11):3674-3682. PubMed ID: 31332499
[TBL] [Abstract][Full Text] [Related]
10. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
[TBL] [Abstract][Full Text] [Related]
12. DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status?
van Heeswijk MM; Lambregts DM; Palm WM; Hendriks BM; Maas M; Beets GL; Beets-Tan RG
AJR Am J Roentgenol; 2017 Mar; 208(3):W79-W84. PubMed ID: 27959622
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Lambregts DM; Vandecaveye V; Barbaro B; Bakers FC; Lambrecht M; Maas M; Haustermans K; Valentini V; Beets GL; Beets-Tan RG
Ann Surg Oncol; 2011 Aug; 18(8):2224-31. PubMed ID: 21347783
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
[TBL] [Abstract][Full Text] [Related]
16. Primary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imaging.
Fornell-Perez R; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Porcel-de-Peralta G; Loro-Ferrer JF
Radiol Med; 2020 Jun; 125(6):522-530. PubMed ID: 32020526
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.
Maas M; Lambregts DM; Nelemans PJ; Heijnen LA; Martens MH; Leijtens JW; Sosef M; Hulsewé KW; Hoff C; Breukink SO; Stassen L; Beets-Tan RG; Beets GL
Ann Surg Oncol; 2015 Nov; 22(12):3873-80. PubMed ID: 26198074
[TBL] [Abstract][Full Text] [Related]
18. Nodal staging in the rectal cancer follow-up MRI after chemoradiotherapy: use of morphology, size, and diffusion criteria.
Fornell-Perez R; Perez-Alonso E; Aleman-Flores P; Lozano-Rodriguez A; Loro-Ferrer JF
Clin Radiol; 2020 Feb; 75(2):100-107. PubMed ID: 31515052
[TBL] [Abstract][Full Text] [Related]
19. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
Wang L; Zhang XY; Zhao YM; Li SJ; Li ZW; Sun YS; Wang WH; Wu AW;
Ann Surg; 2023 Apr; 277(4):647-654. PubMed ID: 35766394
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
